1 |
Liu XH, Yang XJ, Zhan CN, et al. Perineural invasion in adenoid cystic carcinoma of the salivary glands: where we are and where we need to go[J]. Front Oncol, 2020, 10: 1493.
|
2 |
Lee AN, Givi B, Osborn VW, et al. Patterns of care and survival of adjuvant radiation for major salivary adenoid cystic carcinoma[J]. Laryngoscope, 2017, 127(9): 2057-2062.
|
3 |
Fernández-Medarde A, De Las Rivas J, Santos E. 40 years of RAS-A historic overview[J]. Genes (Basel), 2021, 12(5): 681.
|
4 |
Hodge RG, Schaefer A, Howard SV, et al. RAS and RHO family GTPase mutations in cancer: twin sons of different mothers[J]. Crit Rev Biochem Mol Biol, 2020, 55(4): 386-407.
|
5 |
Gilardi M, Wang Z, Proietto M, et al. Tipifarnib as a precision therapy for HRAS-mutant head and neck squamous cell carcinomas[J]. Mol Cancer Ther, 2020, 19(9): 1784-1796.
|
6 |
Subramani PA, Narala VR, Michael RD, et al. Molecular docking and simulation of curcumin with geranylgeranyl transferase1 (GGTase1) and farnesyl transferase (FTase)[J]. Bioinformation, 2015, 11(5): 248-253.
|
7 |
Bagchi S, Rathee P, Jayaprakash V, et al. Farnesyl transferase inhibitors as potential anticancer agents[J]. Mini Rev Med Chem, 2018, 18(19): 1611-1623.
|
8 |
Liu M, Sjogren AKM, Karlsson C, et al. Targeting the protein prenyltransferases efficiently reduces tumor development in mice with K-RAS-induced lung cancer[J]. PNAS, 2010, 107(14): 6471-6476.
|
9 |
Wang M, Casey PJ. Protein prenylation: unique fats ma-ke their mark on biology[J]. Nat Rev Mol Cell Biol, 2016, 17(2): 110-122.
|
10 |
Rowinsky EK, Windle JJ, von Hoff DD. Ras protein farnesyltransferase: a strategic target for anticancer the-rapeutic development[J]. J Clin Oncol, 1999, 17(11): 3631-3652.
|
11 |
Khan SG, Dummer R, Siddiqui J, et al. Farnesyltransfe-rase activity and mRNA expression in human skin basal cell carcinomas[J]. Biochem Biophys Res Commun, 1996, 220(3): 795-801.
|
12 |
盛善桂, 王亚男, 王少如, 等. 体外沉默法尼基转移酶对舌鳞状细胞癌迁移和侵袭的影响[J]. 华西口腔医学杂志, 2020, 38(2): 177-184.
|
|
Sheng SG, Wang YN, Wang SR, et al. Effects of farnesyltransferase silencing on the migration and invasion of tongue squamous cell carcinoma[J]. West China J Stomatol, 2020, 38(2): 177-184.
|
13 |
Laurie SA, Ho AL, Fury MG, et al. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review[J]. Lancet Oncol, 2011, 12(8): 815-824.
|
14 |
Laurie SA, Licitra L. Systemic therapy in the palliative management of advanced salivary gland cancers[J]. J Clin Oncol, 2006, 24(17): 2673-2678.
|
15 |
Moore AR, Rosenberg SC, McCormick F, et al. RAS-targeted therapies: is the undruggable drugged[J]. Nat Rev Drug Discov, 2020, 19(8): 533-552.
|
16 |
Dai W, Xie SQ, Chen CY, et al. Ras sumoylation in cell signaling and transformation[J]. Semin Cancer Biol, 2021, 76: 301-309.
|
17 |
于利洁, 王洁, 董福生, 等. 短发夹状RNA沉默H-ras基因对人涎腺腺样囊性癌细胞增殖的影响[J]. 中华口腔医学杂志, 2008, 43(2): 113-117.
|
|
Yu LJ, Wang J, Dong FS, et al. Effect of shRNA-media-ted silence of H-ras gene on proliferation of human SACC-M cells[J]. Chin J Stomatol, 2008, 43(2): 113-117.
|
18 |
An J, Sun JY, Yuan Q, et al. Proteomics analysis of differentially expressed metastasis-associated proteins in adenoid cystic carcinoma cell lines of human salivary gland[J]. Oral Oncol, 2004, 40(4): 400-408.
|
19 |
张引成, 金晓明, 李雅馨, 等. 癌基因抑癌基因与涎腺肿瘤[J]. 现代口腔医学杂志, 2000, 14(1): 60-62.
|
|
Zhang YC, Jin XM, Li YX, et al. Oncogene, tumor suppressor gene and salivary gland tumor[J]. J Mod Stomatol, 2000, 14(1): 60-62.
|
20 |
Sefton BM, Trowbridge IS, Cooper JA, et al. The transforming proteins of Rous sarcoma virus, Harvey sarcoma virus and Abelson virus contain tightly bound lipid[J]. Cell, 1982, 31(2Pt 1): 465-474.
|
21 |
Willumsen BM, Christensen A, Hubbert NL, et al. The p21 ras C-terminus is required for transformation and membrane association[J]. Nature, 1984, 310(5978): 583-586.
|
22 |
Lee KH, Koh M, Moon A. Farnesyl transferase inhibitor FTI-277 inhibits breast cell invasion and migration by blocking H-Ras activation[J]. Oncol Lett, 2016, 12(3): 2222-2226.
|
23 |
Furfine ES, Leban JJ, Landavazo A, et al. Protein farnesyltransferase: kinetics of farnesyl pyrophosphate binding and product release[J]. Biochemistry, 1995, 34(20): 6857-6862.
|
24 |
Philips MR, Cox AD. Geranylgeranyltransferase Ⅰ as a target for anti-cancer drugs[J]. J Clin Invest, 2007, 117(5): 1223-1225.
|